Genome Sequencing, Polymorphisms, and Pharmacogenomics | MIT HST.508

Added:

Genetic Reductionism and the Limitations of Genomic Determinism

While genome sequencing and pharmacogenomics offer powerful tools for personalized medicine, a significant critique is their tendency toward genetic reductionism—the belief that DNA sequences and polymorphisms alone dictate phenotypic outcomes. Critics argue that this genomic-centric view overlooks the critical influence of the "exposome" (environmental exposures, lifestyle, and socioeconomic factors) and epigenetic modifications, which dynamically alter gene expression without changing the underlying DNA sequence. Furthermore, the "missing heritability" problem highlights that many common polymorphisms fail to explain the majority of phenotypic variance for complex diseases. Additionally, because existing genomic databases predominantly feature data from individuals of European ancestry, relying solely on these models can perpetuate health inequities and limit clinical utility for globally diverse populations. Consequently, many researchers advocate for a holistic systems-biology approach that integrates genomics with proteomics, metabolomics, and environmental data rather than relying on sequence data in isolation.

The Central Dogma of Molecular Biology, specifically how DNA is transcribed to RNA and translated into functional proteins.
Basic genetic terminology and concepts, including genes, alleles, genotypes, phenotypes, and heterozygous versus homozygous states.
Fundamental structure of DNA, including nucleotide base-pairing, codons, and chromosomes.
Introductory principles of population genetics, such as natural selection, genetic drift, and allele frequency.
Genome-Wide Association Studies (GWAS) to statistically link genetic variants to complex diseases and traits.
Clinical implementation of pharmacogenomics, including how variations in metabolic enzymes (such as the Cytochrome P450 family) dictate personalized drug selection and dosing.
Computational bioinformatics pipelines used for next-generation sequencing (NGS) data analysis, variant calling, and annotation.
The ethical, legal, and social implications (ELSI) of direct-to-consumer genetic testing, personalized medicine, and genomic privacy.
1.5K views17likes59:31@mitocwOriginal Release: 2022-08-22

This lecture covers the fundamental principles of population genetics, explaining how mutations arise through various mechanisms (substitutions, deletions, duplications, inversions, translocations, and recombination), how these mutations are represented bioinformatically, and how their frequencies in populations are determined by the interplay of mutation, genetic drift, and natural selection. The course emphasizes practical applications including association studies for identifying disease-causing alleles, haplotype analysis for understanding linked genetic variants, and pharmacogenomics for personalized medicine. Key concepts include the distinction between mutations (rare alleles <1% frequency) and polymorphisms (common alleles >1% frequency), the role of population size in determining whether selection or drift dominates allele frequency changes, and the importance of considering recombination in evolutionary models.